img

Global Therapeutic Proteins and Oral Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Proteins and Oral Vaccines Market Insights, Forecast to 2034

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
Market Analysis and InsightsGlobal Therapeutic Proteins and Oral Vaccines Market
Global Therapeutic Proteins and Oral Vaccines market is expected to reach to US$ 450 million in 2024, with a positive growth of %, compared with US$ 426 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Therapeutic Proteins and Oral Vaccines industry is evaluated to reach US$ 634.7 million in 2029. The CAGR will be 5.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Therapeutic Proteins and Oral Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Therapeutic Proteins and Oral Vaccines market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Segment by Type
Therapeutic Proteins
Oral Vaccines

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Therapeutic Proteins and Oral Vaccines introduction, etc. Therapeutic Proteins and Oral Vaccines Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Therapeutic Proteins and Oral Vaccines
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Therapeutic Proteins
1.2.3 Oral Vaccines
1.3 Market by Application
1.3.1 Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Proteins and Oral Vaccines Market Perspective (2018-2029)
2.2 Global Therapeutic Proteins and Oral Vaccines Growth Trends by Region
2.2.1 Therapeutic Proteins and Oral Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Proteins and Oral Vaccines Historic Market Size by Region (2018-2024)
2.2.3 Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Proteins and Oral Vaccines Market Dynamics
2.3.1 Therapeutic Proteins and Oral Vaccines Industry Trends
2.3.2 Therapeutic Proteins and Oral Vaccines Market Drivers
2.3.3 Therapeutic Proteins and Oral Vaccines Market Challenges
2.3.4 Therapeutic Proteins and Oral Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Therapeutic Proteins and Oral Vaccines by Players
3.1.1 Global Therapeutic Proteins and Oral Vaccines Revenue by Players (2018-2024)
3.1.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Players (2018-2024)
3.2 Global Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Therapeutic Proteins and Oral Vaccines, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio
3.4.1 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Proteins and Oral Vaccines Revenue in 2022
3.5 Global Key Players of Therapeutic Proteins and Oral Vaccines Head office and Area Served
3.6 Global Key Players of Therapeutic Proteins and Oral Vaccines, Product and Application
3.7 Global Key Players of Therapeutic Proteins and Oral Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Proteins and Oral Vaccines Breakdown Data by Type
4.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Type (2018-2024)
4.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2024-2029)
5 Therapeutic Proteins and Oral Vaccines Breakdown Data by Application
5.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Application (2018-2024)
5.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
6.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Type
6.2.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024)
6.2.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
6.2.3 North America Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Application
6.3.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024)
6.3.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
6.3.3 North America Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
6.4 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
6.4.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
6.4.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
7.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type
7.2.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024)
7.2.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
7.2.3 Europe Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application
7.3.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024)
7.3.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
7.3.3 Europe Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
7.4 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
7.4.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
7.4.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
8.2 China Therapeutic Proteins and Oral Vaccines Market Size by Type
8.2.1 China Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024)
8.2.2 China Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
8.2.3 China Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
8.3 China Therapeutic Proteins and Oral Vaccines Market Size by Application
8.3.1 China Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024)
8.3.2 China Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
8.3.3 China Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
9.2 Asia Therapeutic Proteins and Oral Vaccines Market Size by Type
9.2.1 Asia Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024)
9.2.2 Asia Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
9.2.3 Asia Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
9.3 Asia Therapeutic Proteins and Oral Vaccines Market Size by Application
9.3.1 Asia Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024)
9.3.2 Asia Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
9.3.3 Asia Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
9.4 Asia Therapeutic Proteins and Oral Vaccines Market Size by Region
9.4.1 Asia Therapeutic Proteins and Oral Vaccines Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024)
9.4.3 Asia Therapeutic Proteins and Oral Vaccines Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type
10.2.1 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application
10.3.1 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country
10.4.1 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Therapeutic Proteins and Oral Vaccines Introduction
11.1.4 Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.1.5 Abbott Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Therapeutic Proteins and Oral Vaccines Introduction
11.2.4 Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.2.5 Amgen Recent Developments
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Therapeutic Proteins and Oral Vaccines Introduction
11.3.4 Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.3.5 Biogen Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Introduction
11.4.4 Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.4.5 Eli Lilly and Company Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Therapeutic Proteins and Oral Vaccines Introduction
11.5.4 Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Introduction
11.6.4 Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.6.5 Johnson and Johnson Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Proteins and Oral Vaccines Introduction
11.7.4 Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.7.5 Merck Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Introduction
11.8.4 Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.8.5 Novo Nordisk Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Introduction
11.9.4 Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.9.5 Pfizer Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Introduction
11.10.4 Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.10.5 Sanofi Recent Developments
11.11 Serum Institute of India
11.11.1 Serum Institute of India Company Details
11.11.2 Serum Institute of India Business Overview
11.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Introduction
11.11.4 Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.11.5 Serum Institute of India Recent Developments
11.12 Emergent Biosolutions
11.12.1 Emergent Biosolutions Company Details
11.12.2 Emergent Biosolutions Business Overview
11.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Introduction
11.12.4 Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.12.5 Emergent Biosolutions Recent Developments
11.13 TransAlgae
11.13.1 TransAlgae Company Details
11.13.2 TransAlgae Business Overview
11.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Introduction
11.13.4 TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.13.5 TransAlgae Recent Developments
11.14 MigVax
11.14.1 MigVax Company Details
11.14.2 MigVax Business Overview
11.14.3 MigVax Therapeutic Proteins and Oral Vaccines Introduction
11.14.4 MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.14.5 MigVax Recent Developments
11.15 Lumen Bioscience
11.15.1 Lumen Bioscience Company Details
11.15.2 Lumen Bioscience Business Overview
11.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Introduction
11.15.4 Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
11.15.5 Lumen Bioscience Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Therapeutic Proteins
Table 3. Key Players of Oral Vaccines
Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2018-2024)
Table 8. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Therapeutic Proteins and Oral Vaccines Market Share by Region (2024-2029)
Table 10. Therapeutic Proteins and Oral Vaccines Market Trends
Table 11. Therapeutic Proteins and Oral Vaccines Market Drivers
Table 12. Therapeutic Proteins and Oral Vaccines Market Challenges
Table 13. Therapeutic Proteins and Oral Vaccines Market Restraints
Table 14. Global Therapeutic Proteins and Oral Vaccines Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players (2018-2024)
Table 16. Global Top Therapeutic Proteins and Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2022)
Table 17. Global Therapeutic Proteins and Oral Vaccines Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Therapeutic Proteins and Oral Vaccines, Headquarters and Area Served
Table 20. Global Key Players of Therapeutic Proteins and Oral Vaccines, Product and Application
Table 21. Global Key Players of Therapeutic Proteins and Oral Vaccines, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2018-2024)
Table 25. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2024-2029)
Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Application (2018-2024)
Table 29. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Application (2024-2029)
Table 31. North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Therapeutic Proteins and Oral Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Therapeutic Proteins and Oral Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Therapeutic Proteins and Oral Vaccines Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Therapeutic Proteins and Oral Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Therapeutic Proteins and Oral Vaccines Product
Table 66. Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Therapeutic Proteins and Oral Vaccines Product
Table 71. Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 72. Amgen Recent Developments
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Therapeutic Proteins and Oral Vaccines Product
Table 76. Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 77. Biogen Recent Developments
Table 78. Eli Lilly and Company Company Details
Table 79. Eli Lilly and Company Business Overview
Table 80. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product
Table 81. Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 82. Eli Lilly and Company Recent Developments
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Therapeutic Proteins and Oral Vaccines Product
Table 86. Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 87. Roche Recent Developments
Table 88. Johnson and Johnson Company Details
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product
Table 91. Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 92. Johnson and Johnson Recent Developments
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Therapeutic Proteins and Oral Vaccines Product
Table 96. Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 97. Merck Recent Developments
Table 98. Novo Nordisk Company Details
Table 99. Novo Nordisk Business Overview
Table 100. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product
Table 101. Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 102. Novo Nordisk Recent Developments
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Therapeutic Proteins and Oral Vaccines Product
Table 106. Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 107. Pfizer Recent Developments
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Therapeutic Proteins and Oral Vaccines Product
Table 111. Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 112. Sanofi Recent Developments
Table 113. Serum Institute of India Company Details
Table 114. Serum Institute of India Business Overview
Table 115. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product
Table 116. Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 117. Serum Institute of India Recent Developments
Table 118. Emergent Biosolutions Company Details
Table 119. Emergent Biosolutions Business Overview
Table 120. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product
Table 121. Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 122. Emergent Biosolutions Recent Developments
Table 123. TransAlgae Company Details
Table 124. TransAlgae Business Overview
Table 125. TransAlgae Therapeutic Proteins and Oral Vaccines Product
Table 126. TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 127. TransAlgae Recent Developments
Table 128. MigVax Company Details
Table 129. MigVax Business Overview
Table 130. MigVax Therapeutic Proteins and Oral Vaccines Product
Table 131. MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 132. MigVax Recent Developments
Table 133. Lumen Bioscience Company Details
Table 134. Lumen Bioscience Business Overview
Table 135. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product
Table 136. Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2018-2024) & (US$ Million)
Table 137. Lumen Bioscience Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Therapeutic Proteins and Oral Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Therapeutic Proteins Features
Figure 4. Oral Vaccines Features
Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Therapeutic Proteins and Oral Vaccines Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Therapeutic Proteins and Oral Vaccines Report Years Considered
Figure 11. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Therapeutic Proteins and Oral Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Therapeutic Proteins and Oral Vaccines Market Share by Region: 2022 VS 2029
Figure 14. Global Therapeutic Proteins and Oral Vaccines Market Share by Players in 2022
Figure 15. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2022
Figure 17. North America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
Figure 19. North America Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
Figure 20. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 21. United States Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Therapeutic Proteins and Oral Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
Figure 25. Europe Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
Figure 26. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 27. Germany Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Therapeutic Proteins and Oral Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
Figure 35. China Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
Figure 36. Asia Therapeutic Proteins and Oral Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
Figure 38. Asia Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
Figure 39. Asia Therapeutic Proteins and Oral Vaccines Market Share by Region (2018-2029)
Figure 40. Japan Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2018-2029)
Figure 50. Brazil Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 57. Amgen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 58. Biogen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 60. Roche Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 61. Johnson and Johnson Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 62. Merck Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 63. Novo Nordisk Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 64. Pfizer Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 65. Sanofi Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 66. Serum Institute of India Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 67. Emergent Biosolutions Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 68. TransAlgae Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 69. MigVax Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 70. Lumen Bioscience Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries